Answers are grounded in this paper and cite their sources.
This paper shows considerable clinical and radiographic improvements after MINST, therefore bringing evidence to support its efficacy for the treatment of intrabony defects in non-smokers.
No takes yet. Share an insight, caveat, or question.
Nibali et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: